This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sarukhan, A.
Right arrow Articles by Jooss, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sarukhan, A.
Right arrow Articles by Jooss, K.

 Previous Article  |  Next Article 

Journal of Virology, January 2001, p. 269-277, Vol. 75, No. 1
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.1.269-277.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Successful Interference with Cellular Immune Responses to Immunogenic Proteins Encoded by Recombinant Viral Vectors

Adelaida Sarukhan,1 Sabine Camugli,2 Bernard Gjata,2 Harald von Boehmer,3 Olivier Danos,2 and Karin Jooss2,*

Genethon III, 91002 Evry,2 and Institut Necker, INSERM 345, Paris,1 France, and Dana-Farber Cancer Center, Harvard University, Boston, Massachusetts3

Received 13 July 2000/Accepted 25 September 2000

Vectors derived from the adeno-associated virus (AAV) have been successfully used for the long-term expression of therapeutic genes in animal models and patients. One of the major advantages of these vectors is the absence of deleterious immune responses following gene transfer. However, AAV vectors, when used in vaccination studies, can result in efficient humoral and cellular responses against the transgene product. It is therefore important to understand the factors which influence the establishment of these immune responses in order to design safe and efficient procedures for AAV-based gene therapies. We have compared T-cell activation against a strongly immunogenic protein, the influenza virus hemagglutinin (HA), which is synthesized in skeletal muscle following gene transfer with an adenovirus (Ad) or an AAV vector. In both cases, cellular immune responses resulted in the elimination of transduced muscle fibers within 4 weeks. However, the kinetics of CD4+ T-cell activation were markedly delayed when AAV vectors were used. Upon recombinant Ad (rAd) gene transfer, T cells were activated both by direct transduction of dendritic cells and by cross-presentation of the transgene product, while upon rAAV gene transfer T cells were only activated by the latter mechanism. These results suggested that activation of the immune system by the transgene product following rAAV-mediated gene transfer might be easier to control than that following rAd-mediated gene transfer. Therefore, we tested protocols aimed at interfering with either antigen presentation by blocking the CD40/CD40L pathway or with the T-cell response by inducing transgene-specific tolerance. Long-term expression of the AAV-HA was achieved in both cases, whereas immune responses against Ad-HA could not be prevented. These data clearly underline the importance of understanding the mechanisms by which vector-encoded proteins are recognized by the immune system in order to specifically interfere with them and to achieve safe and stable gene transfer in clinical trials.

* Corresponding author. Mailing address: Genethon III, 1 Rue de l'Internationale, 91002 Evry, France. Phone: 33-1-69471039. Fax: 33-1-60778698. E-mail: jooss{at}genethon.fr.

Journal of Virology, January 2001, p. 269-277, Vol. 75, No. 1
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.1.269-277.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Mays, L. E., Vandenberghe, L. H., Xiao, R., Bell, P., Nam, H.-J., Agbandje-McKenna, M., Wilson, J. M. (2009). Adeno-Associated Virus Capsid Structure Drives CD4-Dependent CD8+ T Cell Response to Vector Encoded Proteins. J. Immunol. 182: 6051-6060 [Abstract] [Full Text]  
  • Velazquez, V. M., Bowen, D. G., Walker, C. M. (2009). Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy. Blood 113: 538-545 [Abstract] [Full Text]  
  • Xin, K.-Q., Mizukami, H., Urabe, M., Toda, Y., Shinoda, K., Yoshida, A., Oomura, K., Kojima, Y., Ichino, M., Klinman, D., Ozawa, K., Okuda, K. (2006). Induction of Robust Immune Responses against Human Immunodeficiency Virus Is Supported by the Inherent Tropism of Adeno-Associated Virus Type 5 for Dendritic Cells. J. Virol. 80: 11899-11910 [Abstract] [Full Text]  
  • Gross, D.-A., Chappert, P., Leboeuf, M., Monteilhet, V., Van Wittenberghe, L., Danos, O., Davoust, J. (2006). Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products. Blood 108: 1841-1848 [Abstract] [Full Text]  
  • Harui, A., Roth, M. D., Vira, D., Sanghvi, M., Mizuguchi, H., Basak, S. K. (2006). Adenoviral-encoded antigens are presented efficiently by a subset of dendritic cells expressing high levels of {alpha}v{beta}3 integrins. J. Leukoc. Biol. 79: 1271-1278 [Abstract] [Full Text]  
  • Wang, L., Dobrzynski, E., Schlachterman, A., Cao, O., Herzog, R. W. (2005). Systemic protein delivery by muscle-gene transfer is limited by a local immune response. Blood 105: 4226-4234 [Abstract] [Full Text]  
  • Isayeva, T., Ren, C., Ponnazhagan, S. (2005). Recombinant Adeno-Associated Virus 2-Mediated Antiangiogenic Prevention in a Mouse Model of Intraperitoneal Ovarian Cancer. Clin. Cancer Res. 11: 1342-1347 [Abstract] [Full Text]  
  • Mercier, S., Verhaagh, S., Goudsmit, J., Lemckert, A., Monteil, M., Havenga, M., Eloit, M. (2004). Adenovirus fibre exchange alters cell tropism in vitro but not transgene-specific T CD8+ immune responses in vivo. J. Gen. Virol. 85: 1227-1236 [Abstract] [Full Text]  
  • Palmer, G. A., Brogdon, J. L., Constant, S. L., Tattersall, P. (2004). A Nonproliferating Parvovirus Vaccine Vector Elicits Sustained, Protective Humoral Immunity following a Single Intravenous or Intranasal Inoculation. J. Virol. 78: 1101-1108 [Abstract] [Full Text]  
  • Gross, D.-A., Leboeuf, M., Gjata, B., Danos, O., Davoust, J. (2003). CD4+CD25+ regulatory T cells inhibit immune-mediated transgene rejection. Blood 102: 4326-4328 [Abstract] [Full Text]  
  • Stumptner-Cuvelette, P., Jouve, M., Helft, J., Dugast, M., Glouzman, A.-S., Jooss, K., Raposo, G., Benaroch, P. (2003). Human Immunodeficiency Virus-1 Nef Expression Induces Intracellular Accumulation of Multivesicular Bodies and Major Histocompatibility Complex Class II Complexes: Potential Role of Phosphatidylinositol 3-Kinase. Mol. Biol. Cell 14: 4857-4870 [Abstract] [Full Text]  
  • Molinier-Frenkel, V., Prevost-Blondel, A., Hong, S.-S., Lengagne, R., Boudaly, S., Magnusson, M. K., Boulanger, P., Guillet, J.-G. (2003). The Maturation of Murine Dendritic Cells Induced by Human Adenovirus Is Mediated by the Fiber Knob Domain. J. Biol. Chem. 278: 37175-37182 [Abstract] [Full Text]  
  • Favre, D., Blouin, V., Provost, N., Spisek, R., Porrot, F., Bohl, D., Marme, F., Cherel, Y., Salvetti, A., Hurtrel, B., Heard, J.-M., Riviere, Y., Moullier, P. (2002). Lack of an Immune Response against the Tetracycline-Dependent Transactivator Correlates with Long-Term Doxycycline-Regulated Transgene Expression in Nonhuman Primates after Intramuscular Injection of Recombinant Adeno-Associated Virus. J. Virol. 76: 11605-11611 [Abstract] [Full Text]  
  • Chamberlain, J. S. (2002). Gene therapy of muscular dystrophy. Hum Mol Genet 11: 2355-2362 [Abstract] [Full Text]  
  • Varnavski, A. N., Zhang, Y., Schnell, M., Tazelaar, J., Louboutin, J.-P., Yu, Q.-C., Bagg, A., Gao, G.-p., Wilson, J. M. (2002). Preexisting Immunity to Adenovirus in Rhesus Monkeys Fails To Prevent Vector-Induced Toxicity. J. Virol. 76: 5711-5719 [Abstract] [Full Text]  
  • Mercier, S., Gahery-Segard, H., Monteil, M., Lengagne, R., Guillet, J.-G., Eloit, M., Denesvre, C. (2002). Distinct Roles of Adenovirus Vector-Transduced Dendritic Cells, Myoblasts, and Endothelial Cells in Mediating an Immune Response against a Transgene Product. J. Virol. 76: 2899-2911 [Abstract] [Full Text]  
  • Guillot, C., Guillonneau, C., Mathieu, P., Gerdes, C. A., Menoret, S., Braudeau, C., Tesson, L., Renaudin, K., Castro, M. G., Lowenstein, P. R., Anegon, I. (2002). Prolonged Blockade of CD40-CD40 Ligand Interactions by Gene Transfer of CD40Ig Results in Long-Term Heart Allograft Survival and Donor-Specific Hyporesponsiveness, But Does Not Prevent Chronic Rejection. J. Immunol. 168: 1600-1609 [Abstract] [Full Text]  
  • Prasad, S. A., Norbury, C. C., Chen, W., Bennink, J. R., Yewdell, J. W. (2001). Cutting Edge: Recombinant Adenoviruses Induce CD8 T Cell Responses to an Inserted Protein Whose Expression Is Limited to Nonimmune Cells. J. Immunol. 166: 4809-4812 [Abstract] [Full Text]  
  • Jooss, K., Gjata, B., Danos, O., von Boehmer, H., Sarukhan, A. (2001). Regulatory function of in vivo anergized CD4+ T cells. Proc. Natl. Acad. Sci. USA 98: 8738-8743 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»